FMCG major HUL on Thursday said it expects the merger of GlaxoSmithKline Consumer Healthcare (GSKCH India) through an-all equity deal to complete in six-nine months due to pending clearances from various authorities.
The company has already initiated the process of getting approval and has already initiated integration teams, said HUL Chief Financial Officer Srinivas Phatak.
"Once we get the court's approval, GSK Consumer India would merge into HUL. That process, we expected to take between 6 to 9 months because we require various authorities clarences," said Srinivas Phatak in a post earning conference call.
He further said: "We are now in the process of getting various approvals."
However, Phatak also added: "We have initiated integration teams with HUL to first landing on how we want to do it and we can not do it physically till we get approval."